Skip to main content

Prism Inks 300,000 SF Lease at ON3 With Japanese Pharmaceutical Company

Eisai, an oncology and neurology-focused pharmaceutical company, is the latest firm to call Prism’s On3 campus home.

Leave a Reply

Your email address will not be published. Required fields are marked *